bile duct cancer FDA Approves Bile Duct Cancer Drug from Helsinn, BridgeBio Pharma With Foundation Medicine CDx Truseltiq is a new option for FGFR2 fusion-positive, locally advanced, or metastatic cholangiocarcinoma patients who have received prior treatment. Incyte's Pemazyre, Foundation Medicine CDx Get FDA Approval for FGFR2-Mutated Bile Duct Cancer The FDA approved the drug based on data on response rate but continued approval is contingent on the results of a randomized study showing a PFS and OS advantage. Foundation Medicine, QED Therapeutics to Develop CDx for Bile Duct Cancer The CDx, which will include the detection of activating FGFR2 fusions, is expected to be incorporated into Foundation Medicine's FDA-approved FoundationOne CDx assay. Foundation Medicine, Incyte Partner on CDx Development The companies initially expect to incorporate a CDx for Incyte's pemigatinib into Foundation Medicine's existing FDA-approved assay, FoundationOne CDx. George Washington University Team Wins $1.7M NCI Grant to Study Cancer-Causing Parasite The researchers are studying the molecular links between bile duct cancer and liver fluke infection, and testing a vaccine to protect against infection. Jul 8, 2015 Aslan, ACT to Study Exceptional Responders to Pan-HER Inhibitor Jul 17, 2014 NeoGenomics Q2 Revenues Rise 33 Percent on Test Volume Nov 7, 2013 Genomics in the Journals Nov 7, 2013 May 7, 2012 Exome Sequencing IDs Mutations in Liver Fluke-Associated Bile Duct Cancer Jun 16, 2011 GWU Researchers Awarded $500K by NCI to Develop Biomarkers for Bile Duct Cancer Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.